Mechanisms of Maladaptation in Heart Failure
Duke University, Durham NC
Investigators
Linked publications & trials
Abstract
DESCRIPTION (provided by applicant): ß-arrestins were initially discovered to desensitize GPCR signaling in response to agonist stimulation. However, it is now appreciated that ß-arrestins can also transduce multiple effector pathways independent of G-protein signaling when receptors are stimulated by certain ligands, a concept known as biased signaling. The proposed mechanism for this signaling bias is based on the barcode hypothesis where unbiased and ß-arrestin-biased ligands impart distinct patterns of receptor phosphorylation by specific GPCR kinases (GRKs), thus converting a distinct ligand stabilized receptor conformation into selective ß-arrestin function and downstream signaling. In this proposal we plan to discover new mechanistic insights for the precise molecular details that underlie ß-arrestin biased signaling and determine how this may influence cardiac function. We will use a mass spectrometry phosphoproteomic based approach to determine whether Carvedilol induces a unique phosphorylation bar code of the ß1AR compared to the balance agonist isoproterenol, and will translate these findings in vivo by using mice conditionally lacking ß-arrestin in differnt cell types of the heart and determine the effect of ß-arrestin bias on the transcriptional signatue and cardiac function under normal and injured conditions. We propose the following specific aims: Aim 1: Determine the specific phosphorylation bar code on the c-terminal tail of ß1AR responsible for G?i dependent ß-arrestin-biased signaling. Aim 2: Determine the mechanism of ß1AR-biased signaling in cardiac fibroblasts. Aim 3: Determine the cardiac cell type responsible for ß-arrestin signaling that promotes cardiac fibrosis in response to injury. Aim 4: Determine th cell-type specific RNA signature of wild type and conditionally deleted ß-arrestin1 and 2 KO mice in response to the biased ligand carvedilol and after cardiac injury.
View original record on NIH RePORTER →